Donate to pancreatic cancer research at MSK
Pancreatic cancer is diagnosed in over 67,000 Americans each year and is the third-leading cause of cancer-related death in the U.S. At Memorial Sloan Kettering Cancer Center (MSK), pancreatic cancer experts are making progress toward new and better treatments every day, and your donations fuel their work.
Your support fuels breakthroughs
Thanks to donors, MSK is a leader in pancreatic cancer research and care. U.S. News & World Report ranked us as the #2 cancer hospital in the country and Charity Navigator gave us its highest rating.
We’ve made considerable progress in pancreatic cancer research
Donor support has enabled MSK’s many advancements:
- Finding new insights into the relationship between the immune system and pancreatic cancer that led to a first-of-its kind mRNA vaccine trial.
- Developing liquid biopsy tools like MSK-ACCESS® that can detect cancer using a blood draw and help diagnose pancreatic cancers at earlier, more treatable stages.
- Identifying and targeting genetic mutations that can cause cancer.
- Learning why some tumors develop resistance to a type of drug known as KRAS inhibitors and how to make these treatments more effective.
And we’re creating even more hope for tomorrow
Your charitable gift will fund the next wave of breakthroughs in pancreatic cancer research at MSK:
- Understanding the ecosystem around pancreatic tumors — and its impact on how pancreatic cancer grows, spreads, and responds to therapy.
- Studying the interactions between genetic mutations and external factors to learn how to spot the disease earlier, when it’s more treatable.
- Accelerating precision vaccines as the next breakthrough therapy for pancreatic and other challenging cancers.
- Testing off-the-shelf vaccines as a new treatment approach to prevent or delay pancreatic cancer recurrence.
Donate in honor or memory and fund the next discovery in pancreatic cancer research and care at MSK.
Making science personal
Donors fuel MSK’s pancreatic cancer advances
Improving lives with innovation
Established in 2014 with generous philanthropic support, the David M. Rubenstein Center for Pancreatic Cancer Research is a world-leading multidisciplinary hub dedicated exclusively to pancreatic cancer research and care.
Learn morePioneering cancer vaccines
The Olayan Center for Cancer Vaccines at MSK brings together world-renowned researchers and clinicians to lead the field in developing vaccines that target a wide range of cancers, including pancreatic cancer.
Read moreDefeating cancer with data
MSK established a Pancreatic Tumor Registry to collect and study data that can help researchers learn why people develop pancreatic cancer, and how to better treat it.
Learn moreDiscovering new treatments
Clinical trials are crucial to getting promising new treatments to people who need them. MSK’s robust clinical trials program can give people with pancreatic cancer options they wouldn’t have at other hospitals.
Learn moreHelp accelerate lifesaving pancreatic cancer research.
